End of an era: Sartorius boss steps down

Supervisory Board expresses great regret

03-Jul-2024 - The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be seeking another extension of his current contract when it expires in November 2025. The Supervisory Board has taken note ...

Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor

Manufacturing of instruments, consumables and reagents for cell and protein analysis

07-Jun-2024 - The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park. Sartorius has invested around 100 million US dollars in the state-of-the-art facility, consolidating existing sites and ...

Sartorius collaborates with Sanofi to

Commercialization of end-to-end platform for downstream process intensification

20-May-2024 - The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to ...

Sartorius expects profitable growth in 2024

Double-digit annual sales revenue growth projected through to 2028

31-Jan-2024 - Sartorius expects a return to profitable growth in 2024 and a dynamic business development for the five-year period through to 2028. In 2023, soft demand, which lasted longer than expected post-pandemic, led to a temporary decline in sales revenue and earnings across the entire life science ...

Sartorius forms partnership with SPARTA Biodiscovery on novel nanoparticle analysis platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs

02-Oct-2023 - The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. Nanoparticles are small polymer or lipid capsules ...

Sartorius opens manufacturing facility for cell culture media in Puerto Rico

Expansion of capacities for manufacturing powder media with focus on the Americas region

25-Jul-2023 - Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has added a cell culture media manufacturing facility to its existing site in Yauco, Puerto Rico. The 21,500-square-foot (2,000 square meters) facility, which was officially opened, will expand ...

Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

06-Jun-2023 - Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ ...

First quarter of Sartorius characterized by normalization of demand

Full-year outlook confirmed: uncertainties remain high due to the global political and economic situation

21-Apr-2023 - After the Covid-19-related business and inventory buildup by customers had triggered strong additional growth momentum in previous years, demand normalization at the life science group Sartorius continued throughout the first quarter of 2023, as expected, and led to a decline in sales revenue and ...

Sartorius acquires French provider of innovative upstream technologies for cell and gene therapies

Agreed purchase price of approximately 2.4 billion euros

03-Apr-2023 - The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has signed an agreement to acquire Polyplus for approximately 2.4 billion euros from private investors including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg Pincus. Polyplus, with ...

Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division

31-Mar-2023 - The Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerry Mackay, Board Member and Head of the Lab Products & Services division, who will hand over duties in the ...